nodes	percent_of_prediction	percent_of_DWPC	metapath
Misoprostol—Menstrual disorder—Varenicline—nicotine dependence	0.0301	0.0492	CcSEcCtD
Misoprostol—Menorrhagia—Varenicline—nicotine dependence	0.0278	0.0453	CcSEcCtD
Misoprostol—Gingivitis—Varenicline—nicotine dependence	0.0262	0.0427	CcSEcCtD
Misoprostol—Glycosuria—Varenicline—nicotine dependence	0.0254	0.0414	CcSEcCtD
Misoprostol—PTGER3—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.0216	0.0564	CbGpPWpGaD
Misoprostol—Pulmonary embolism—Varenicline—nicotine dependence	0.0205	0.0335	CcSEcCtD
Misoprostol—Urine output increased—Varenicline—nicotine dependence	0.0186	0.0303	CcSEcCtD
Misoprostol—PTGER4—GPCR ligand binding—TAS2R16—nicotine dependence	0.0173	0.0451	CbGpPWpGaD
Misoprostol—Polyuria—Varenicline—nicotine dependence	0.017	0.0277	CcSEcCtD
Misoprostol—Deafness—Varenicline—nicotine dependence	0.0167	0.0272	CcSEcCtD
Misoprostol—Thirst—Varenicline—nicotine dependence	0.0157	0.0256	CcSEcCtD
Misoprostol—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.0149	0.0243	CcSEcCtD
Misoprostol—PTGER2—GPCR ligand binding—TAS2R16—nicotine dependence	0.0142	0.037	CbGpPWpGaD
Misoprostol—Breast disorder—Varenicline—nicotine dependence	0.0135	0.022	CcSEcCtD
Misoprostol—Cramp muscle—Varenicline—nicotine dependence	0.0134	0.0219	CcSEcCtD
Misoprostol—PTGER3—GPCR ligand binding—TAS2R16—nicotine dependence	0.0131	0.0342	CbGpPWpGaD
Misoprostol—Dysphagia—Varenicline—nicotine dependence	0.0129	0.021	CcSEcCtD
Misoprostol—Bronchitis—Varenicline—nicotine dependence	0.0124	0.0202	CcSEcCtD
Misoprostol—Erectile dysfunction—Varenicline—nicotine dependence	0.0119	0.0194	CcSEcCtD
Misoprostol—Acute coronary syndrome—Varenicline—nicotine dependence	0.0113	0.0185	CcSEcCtD
Misoprostol—Myocardial infarction—Varenicline—nicotine dependence	0.0113	0.0184	CcSEcCtD
Misoprostol—Conjunctivitis—Varenicline—nicotine dependence	0.0112	0.0182	CcSEcCtD
Misoprostol—PTGER4—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.0112	0.0291	CbGpPWpGaD
Misoprostol—Epistaxis—Varenicline—nicotine dependence	0.0108	0.0177	CcSEcCtD
Misoprostol—Visual impairment—Varenicline—nicotine dependence	0.00994	0.0162	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00976	0.0255	CbGpPWpGaD
Misoprostol—Tinnitus—Varenicline—nicotine dependence	0.00962	0.0157	CcSEcCtD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00956	0.025	CbGpPWpGaD
Misoprostol—Immune system disorder—Varenicline—nicotine dependence	0.00932	0.0152	CcSEcCtD
Misoprostol—Chills—Varenicline—nicotine dependence	0.00926	0.0151	CcSEcCtD
Misoprostol—Arrhythmia—Varenicline—nicotine dependence	0.00922	0.015	CcSEcCtD
Misoprostol—PTGER2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00916	0.0239	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00911	0.0238	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—TAS2R16—nicotine dependence	0.00886	0.0231	CbGpPWpGaD
Misoprostol—Flatulence—Varenicline—nicotine dependence	0.00885	0.0144	CcSEcCtD
Misoprostol—Back pain—Varenicline—nicotine dependence	0.00869	0.0142	CcSEcCtD
Misoprostol—Muscle spasms—Varenicline—nicotine dependence	0.00863	0.0141	CcSEcCtD
Misoprostol—PTGER3—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00846	0.0221	CbGpPWpGaD
Misoprostol—Anaemia—Varenicline—nicotine dependence	0.0083	0.0136	CcSEcCtD
Misoprostol—PTGER4—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00807	0.0211	CbGpPWpGaD
Misoprostol—Syncope—Varenicline—nicotine dependence	0.00805	0.0131	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00801	0.0209	CbGpPWpGaD
Misoprostol—Loss of consciousness—Varenicline—nicotine dependence	0.00789	0.0129	CcSEcCtD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00785	0.0205	CbGpPWpGaD
Misoprostol—Hypertension—Varenicline—nicotine dependence	0.00775	0.0127	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—FGD1—nicotine dependence	0.00766	0.02	CbGpPWpGaD
Misoprostol—Chest pain—Varenicline—nicotine dependence	0.00765	0.0125	CcSEcCtD
Misoprostol—Myalgia—Varenicline—nicotine dependence	0.00765	0.0125	CcSEcCtD
Misoprostol—Arthralgia—Varenicline—nicotine dependence	0.00765	0.0125	CcSEcCtD
Misoprostol—Anxiety—Varenicline—nicotine dependence	0.00762	0.0124	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—TAS2R16—nicotine dependence	0.0074	0.0193	CbGpPWpGaD
Misoprostol—Oedema—Varenicline—nicotine dependence	0.00733	0.012	CcSEcCtD
Misoprostol—Infection—Varenicline—nicotine dependence	0.00728	0.0119	CcSEcCtD
Misoprostol—PTGER4—GPCR ligand binding—OPRM1—nicotine dependence	0.00728	0.019	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—TAS2R16—nicotine dependence	0.00728	0.019	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00724	0.0189	CbGpPWpGaD
Misoprostol—Shock—Varenicline—nicotine dependence	0.00721	0.0118	CcSEcCtD
Misoprostol—Thrombocytopenia—Varenicline—nicotine dependence	0.00718	0.0117	CcSEcCtD
Misoprostol—Hyperhidrosis—Varenicline—nicotine dependence	0.00709	0.0116	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—FGD1—nicotine dependence	0.00695	0.0182	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00691	0.018	CbGpPWpGaD
Misoprostol—Hypotension—Varenicline—nicotine dependence	0.00685	0.0112	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—TAS2R16—nicotine dependence	0.00672	0.0175	CbGpPWpGaD
Misoprostol—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00668	0.0109	CcSEcCtD
Misoprostol—PTGER2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00662	0.0173	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—DRD2—nicotine dependence	0.00659	0.0172	CbGpPWpGaD
Misoprostol—Dyspnoea—Varenicline—nicotine dependence	0.00653	0.0107	CcSEcCtD
Misoprostol—Somnolence—Varenicline—nicotine dependence	0.00652	0.0106	CcSEcCtD
Misoprostol—Dyspepsia—Varenicline—nicotine dependence	0.00645	0.0105	CcSEcCtD
Misoprostol—Fatigue—Varenicline—nicotine dependence	0.00632	0.0103	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—FGD1—nicotine dependence	0.00629	0.0164	CbGpPWpGaD
Misoprostol—Constipation—Varenicline—nicotine dependence	0.00627	0.0102	CcSEcCtD
Misoprostol—Pain—Varenicline—nicotine dependence	0.00627	0.0102	CcSEcCtD
Misoprostol—PTGER3—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00611	0.016	CbGpPWpGaD
Misoprostol—Feeling abnormal—Varenicline—nicotine dependence	0.00604	0.00986	CcSEcCtD
Misoprostol—Gastrointestinal pain—Varenicline—nicotine dependence	0.00599	0.00979	CcSEcCtD
Misoprostol—PTGER2—GPCR ligand binding—OPRM1—nicotine dependence	0.00598	0.0156	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—FGD1—nicotine dependence	0.0058	0.0152	CbGpPWpGaD
Misoprostol—Body temperature increased—Varenicline—nicotine dependence	0.00579	0.00946	CcSEcCtD
Misoprostol—Abdominal pain—Varenicline—nicotine dependence	0.00579	0.00946	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—FGD1—nicotine dependence	0.00571	0.0149	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00568	0.0148	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—OPRM1—nicotine dependence	0.00552	0.0144	CbGpPWpGaD
Misoprostol—Hypersensitivity—Varenicline—nicotine dependence	0.0054	0.00882	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—FGD1—nicotine dependence	0.00527	0.0138	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—DRD2—nicotine dependence	0.00526	0.0137	CbGpPWpGaD
Misoprostol—Asthenia—Varenicline—nicotine dependence	0.00526	0.00859	CcSEcCtD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00524	0.0137	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TAS2R16—nicotine dependence	0.00523	0.0137	CbGpPWpGaD
Misoprostol—Diarrhoea—Varenicline—nicotine dependence	0.00501	0.00819	CcSEcCtD
Misoprostol—Dizziness—Varenicline—nicotine dependence	0.00485	0.00791	CcSEcCtD
Misoprostol—Vomiting—Varenicline—nicotine dependence	0.00466	0.00761	CcSEcCtD
Misoprostol—Rash—Varenicline—nicotine dependence	0.00462	0.00755	CcSEcCtD
Misoprostol—Dermatitis—Varenicline—nicotine dependence	0.00462	0.00754	CcSEcCtD
Misoprostol—Headache—Varenicline—nicotine dependence	0.00459	0.0075	CcSEcCtD
Misoprostol—Nausea—Varenicline—nicotine dependence	0.00435	0.00711	CcSEcCtD
Misoprostol—PTGER2—GPCR ligand binding—DRD2—nicotine dependence	0.00432	0.0113	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TAS2R16—nicotine dependence	0.0043	0.0112	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—OPRM1—nicotine dependence	0.00411	0.0107	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—FGD1—nicotine dependence	0.00411	0.0107	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—DRD2—nicotine dependence	0.00399	0.0104	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TAS2R16—nicotine dependence	0.00397	0.0104	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—OPRM1—nicotine dependence	0.00374	0.00975	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—AKR1B10—nicotine dependence	0.00363	0.00947	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—OPRM1—nicotine dependence	0.00338	0.00882	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—FGD1—nicotine dependence	0.00337	0.00881	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—OPRM1—nicotine dependence	0.00312	0.00814	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—FGD1—nicotine dependence	0.00311	0.00813	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—OPRM1—nicotine dependence	0.00307	0.00801	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—AKR1B10—nicotine dependence	0.00298	0.00778	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—DRD2—nicotine dependence	0.00297	0.00777	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—OPRM1—nicotine dependence	0.00283	0.00739	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—AKR1B10—nicotine dependence	0.00275	0.00718	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—DRD2—nicotine dependence	0.0027	0.00705	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—WASF2—nicotine dependence	0.00256	0.00668	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—WASF1—nicotine dependence	0.00245	0.0064	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—DRD2—nicotine dependence	0.00244	0.00638	CbGpPWpGaD
Misoprostol—PTGER4—cardiovascular system—nicotine dependence	0.00238	0.525	CbGeAlD
Misoprostol—PTGER3—GPCR downstream signaling—DRD2—nicotine dependence	0.00225	0.00589	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—DRD2—nicotine dependence	0.00222	0.00579	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—OPRM1—nicotine dependence	0.00221	0.00576	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—WASF2—nicotine dependence	0.0021	0.00548	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—DRD2—nicotine dependence	0.00205	0.00534	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—WASF1—nicotine dependence	0.00201	0.00526	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—WASF2—nicotine dependence	0.00194	0.00506	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—WASF1—nicotine dependence	0.00186	0.00485	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—OPRM1—nicotine dependence	0.00181	0.00473	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—OPRM1—nicotine dependence	0.00167	0.00437	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—DRD2—nicotine dependence	0.0016	0.00417	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—DRD2—nicotine dependence	0.00131	0.00342	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—DRD2—nicotine dependence	0.00121	0.00316	CbGpPWpGaD
Misoprostol—PTGER4—brain—nicotine dependence	0.00117	0.257	CbGeAlD
Misoprostol—PTGER3—brain—nicotine dependence	0.000989	0.218	CbGeAlD
